NIH-funded research R03 grant

HPV-related head and neck and cervical cancers: finding key gene networks and lncRNA markers for targeted therapy

Official title: Unveiling Therapeutic Targets for Precision Intervention in HPV-Associated Oral Cancers through Genomic Analysis

Funded at University of Arizona · NIH-11436860 · Data updated 2026-11-12

Researchers will study how HPV-related cervical and head-and-neck cancers differ at the gene and RNA level to uncover potential targets for precision treatment.

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startJuly 8, 2026
Project endJuly 7, 2028
Funding year2026
Award (this year)$284,714
NIH project number1R03DE036395-01
Project IDNIH-11436860 on NIH RePORTER

Who could benefit from this research

Could help

Patients with HPV-associated cervical cancer or HPV-positive oropharyngeal cancers, especially those with available tumor samples or cell-line models.

Less likely to help

Patients without HPV-associated cancers or without access to relevant samples or data may not directly benefit.

What this research studies

This project will compare cervical cancer and HPV-positive oropharyngeal cancers to see how gene networks differ when the virus integrates into the host genome versus existing episomally. By focusing on long non-coding RNAs and how viral E6/E7 proteins influence them, the study aims to identify molecular patterns that could guide targeted therapies. Using patient-derived samples and cell culture models, the team will apply co-expression network analyses to map regulatory relationships and highlight potential intervention points. The work emphasizes HPV16-driven cases, which are the most common in OPSCC, and will distinguish tumors based on viral integration status to understand clinical behavior better.

Why it matters

Potential benefit: If successful, the findings could point to new molecular targets and RNA biomarkers to personalize treatment for HPV-related cervical and head-and-neck cancers.

How similar studies have gone: Previous work has shown that viral integration and RNA expression patterns influence cancer behavior, but the specific role of lncRNAs in HPV-related cancers is still emerging.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Van Doorslaer, Koenraad — University of Arizona
  • Study coordinator: Van Doorslaer, Koenraad

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.